
Boris Quednow
Boris Quednow is an expert in experimental and clinical psychopharmacology at the Psychiatric University Hospital in Zurich. He has expressed concern over the rising popularity of ketamine, particularly among young people, and the potential dangers associated with its use, especially when combined with other stimulants, following an increase in public interest after celebrity endorsements.
Global Media Ratings
Countries Mentioned
Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
---|---|---|---|---|---|---|---|---|
Switzerland | 2 | 4.50 | 0.13% | +10% | 8,654,622 | 12,190 | $700,000 | 986$ |
Totals | 2 | 8,654,622 | 12,190 | $700,000 | 986$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Switzerland:
Boris Quednow is a pharmacopsychologist who discusses the increasing drug problem in Switzerland.
6
Switzerland:
Boris Quednow expresses concern over Elon Musk promoting ketamine use.
3